Trakų medicinos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 211,261 | 173,826 | 282,961 | 310,276 | 271,780 | 295,089 | 249,535 | 232,965 |
| Profit before tax | 74,767 | 36,110 | 95,711 | 94,841 | 84,196 | 85,303 | 18,473 | -27,600 |
| Net profit | 74,767 | 36,110 | 95,711 | 94,841 | 84,196 | 85,303 | 18,473 | -27,600 |
| Equity | 181,981 | 218,091 | 313,802 | 268,643 | 252,839 | 238,142 | 256,615 | 125,262 |
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 17,264 | 45,870 |
| Non-current assets | 32,215 | 57,468 | 84,439 | 65,178 | 45,917 | 26,655 | 104,118 | 40,252 |
| Current assets | 149,766 | 160,623 | 229,363 | 203,465 | 206,922 | 211,487 | 169,761 | 131,349 |
| Total assets | 181,981 | 218,091 | 313,802 | 268,643 | 252,839 | 238,142 | 273,879 | 171,601 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 33,089 | 19,446 | 38,590 |
| Social insurance contributions | - | - | - | - | - | 23,289 | 25,069 | 29,455 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +43.7% | -17.7% | +62.8% | +9.7% | -12.4% | +8.6% | -15.4% | -6.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 41.1% | 16.6% | 30.5% | 35.3% | 33.3% | 35.8% | 6.7% | -16.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 41.1% | 16.6% | 30.5% | 35.3% | 33.3% | 35.8% | 7.2% | -22.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 35.4% | 20.8% | 33.8% | 30.6% | 31.0% | 28.9% | 7.4% | -11.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 35.4% | 20.8% | 33.8% | 30.6% | 31.0% | 28.9% | 7.4% | -11.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | 0.1 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,281 | 16,555 | 22,637 | 25,856 | 22,648 | 23,144 | 19,073 | 21,019 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Trakų medicinos centras - Social security debts
The company had no debts to Sodra
Trakų medicinos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-22 | 2026-01-24 | 8.42 |
| 2026-01-15 | 2026-01-21 | 8.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Traku medicinos centras, UAB (code 302813735) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of €233.0K, down 6.6% year on year and 21.1% over two years. Profitability weakened materially: net result moved from a profit of €85.3K in 2023 to €18.5K in 2024, before turning to a loss of €27.6K in 2025. The 2025 profit margin was -11.8%, reflecting the decline in operating performance.
The balance sheet also contracted in 2025. Total assets stood at €171.6K, compared with €273.9K in 2024, while equity declined to €125.3K from €256.6K. Liabilities increased to €45.9K from €17.3K. The latest ratios show an equity ratio of 73.0% and debt-to-equity of 0.37, indicating a still solid capital base despite weaker results. Asset turnover was 1.36x. Revenue per employee was €21.2K and profit per employee was -€2.5K in 2025.
The balance sheet also contracted in 2025. Total assets stood at €171.6K, compared with €273.9K in 2024, while equity declined to €125.3K from €256.6K. Liabilities increased to €45.9K from €17.3K. The latest ratios show an equity ratio of 73.0% and debt-to-equity of 0.37, indicating a still solid capital base despite weaker results. Asset turnover was 1.36x. Revenue per employee was €21.2K and profit per employee was -€2.5K in 2025.